|
 |
European Pharmaceutical Contractor
|
PharmaCluster Finland is a unique mixture of science and business. The Cluster was created within the framework of the National Centre of Expertise Programme. Its aim is to facilitate development of the new pharma network in Finland. Cluster members represent established industries, start-up companies, research and educational units and also venture capital funds. All the key players in the field are members of the Cluster. This broad base offers good opportunities to influence decision-makers in specific development activities relating to the pharmaceutical industry in Finland.
Finland - Key Strengths:
One of the most important factors in the success story of Finnish high tech is the high level of investment devoted to R&D. In 2002 more than three per cent of the total GDP was invested in future research activities
According to a United Nations Development Programme (UNDP) report released in 2001, Finland is the most advanced country in creating and using technology
The International Institute for Management Development (IMD) ranked Finland second in overall industry competitiveness in 2002
According to the World Economic Forum (WEF), Finland is ranked first in current competitiveness, growth competitiveness and economic creativity. In innovation capacity, Finland is ranked second and in technology third
Finland has more than 140 biotech companies making it sixth in the European ranking
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
MipTec, October 14 – 16, 2008, Switzerland
MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com
More info >> |
|
 |
